Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
N-Biotech is a South Korean biotechnology company specializing in regenerative medicine and cell-based therapies. Founded in 2006, the company focuses on the development of autologous stem cell and natural killer (NK) cell treatments for conditions such as osteoarthritis, hair loss, and various cancers. N-Biotech utilizes proprietary technologies for the isolation and expansion of high-purity cells, supported by its own line of specialized laboratory equipment and GMP-certified manufacturing facilities. Their clinical pipeline includes programs like NB-01 for osteoarthritis and NB-02 for alopecia, both of which leverage adipose-derived stem cells. The company aims to advance personalized medicine through global research collaborations and the commercialization of innovative biological products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on N Biotech.